Meningitis B Vaccination: Protecting Your Child Against a Serious Disease

Meningitis B is a rare but potentially life-threatening bacterial infection that can cause meningitis (inflammation of the lining of the brain and spinal cord) and septicaemia (blood poisoning).

Chen

6/21/20262 min read

What Is Meningitis B?

Meningitis B is caused by the bacterium Neisseria meningitidis group B. The infection can affect people of any age but is most common in:

Babies and young children
Teenagers and young adults
University students
Individuals with certain medical conditions affecting immunity

Even with prompt medical treatment, Meningitis B can cause severe complications including:

Hearing loss
Brain damage
Limb amputations
Learning difficulties
Death

What Are the Symptoms of Meningitis B?

Early symptoms can be difficult to recognise because they often resemble common viral illnesses.

Symptoms may include:

High temperature
Severe headache
Vomiting
Stiff neck
Sensitivity to light
Drowsiness or confusion
Cold hands and feet
Muscle pain
A rash that does not fade when pressed with a glass

If meningitis is suspected, urgent medical attention should be sought immediately.

Who Should Consider Meningitis B Vaccination?

Babies and Young Children

Babies are at the highest risk of developing Meningitis B. Vaccination provides important protection during the years when the risk is greatest.

Teenagers and Young Adults

Although less common than in infancy, Meningitis B can affect teenagers and young adults, particularly those living in close-contact environments such as university accommodation.

Travellers

Some travellers may benefit from meningococcal vaccination depending on their destination and travel plans.

Individuals with Certain Medical Conditions

People with specific immune system disorders may be at increased risk and should discuss vaccination with a healthcare professional.

How Effective Is the Meningitis B Vaccine?

The MenB vaccine stimulates the body's immune system to recognise and fight the bacteria responsible for Meningitis B.

Studies have shown that vaccination significantly reduces the risk of developing invasive MenB disease and has helped lower infection rates where vaccination programmes have been implemented.